surmount-1 tirzepatide weight loss percent 72 weeks for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial Tirzepatide as Anti-Obesity Agent
Pay in 4 interest-free payments of $6.98 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 5 - Oct 10



00377-2/asset/5849e908-c26a-472e-b460-1c99904b95c5/main.assets/gr2.jpg)




















